AstraZeneca Posts Higher H1 Attributable Profit, Revenue
TD Cowen Maintains AstraZeneca(AZN.US) With Buy Rating
Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand
Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), AstraZeneca (AZN) and Icon (ICLR)
AstraZeneca Slips Despite 2024 Guidance Raise on Medicines Demand
Earnings Flash (AZN) ASTRAZENECA Posts Q2 Revenue $12.94B
Viking Sends Lilly, Novo Lower as Obesity Drug Enters Late-stage Program
Press Release: AstraZeneca's H1 and Q2 2024 Financial Results
Trending Stocks Today | Psyence Biomedical Soars 173.37% Pre-Market
Express News | AstraZeneca Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 Adjusted EPS
AstraZeneca: Strong Q2 Performance and Promising Pipeline Justify Buy Rating
Astrazeneca: Q2 Earnings Snapshot
AstraZeneca Hits 8-week Low
AstraZeneca Reports Strong H1 2024 Growth
American Airlines, AstraZeneca And 3 Stocks To Watch Heading Into Thursday
AstraZeneca Guidance Raise Signals Portfolio Potential -- Market Talk
AstraZeneca Raises Guidance After Revenue, Earnings Beat Market Expectations
AstraZeneca Lifts Full-year Outlook on Upbeat Demand for Therapies
AstraZeneca Increased Interim Dividend by 7c to $1.00
AstraZeneca Had Seen Core EPS Grow by Low Double-Digit to Low Teens Percentage Range